Low Hematocrit Is a Strong Predictor of Poor Prognosis in Lung Cancer Patients

Morbidity and mortality of lung cancer rank first in China and worldwide. Thus, noninvasive prognostic biomarkers are critical for clinicians to perform risk assessment in lung cancer patients prior to or during the course of treatment. In this study, we evaluated the prognostic value of preoperativ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomed Res Int
Hauptverfasser: Zhang, Xin, Zhang, Fengmin, Qiao, Wenbo, Zhang, Xiansheng, Zhao, Zhefeng, Li, Mingqi
Format: Artigo
Sprache:Inglês
Veröffentlicht: Hindawi 2018
Schlagworte:
Clinical Study
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6207876/
https://ncbi.nlm.nih.gov/pubmed/30417013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/6804938
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge